MannKind Provides Update on Phase 3 ICoN-1 Trial of Nebulized Clofazimine for NTM Lung Disease
MannKind MannKind has made the decision to discontinue the ICoN-1 Phase 3 clinical trial evaluating nebulized clofazimine inhalation…
Blood biomarkers offer hope for early detection of interstitial lung disease
UVA Health lung researchers are developing a promising approach to detecting patients at risk of interstitial lung disease…
Singing helps patients with COPD and interstitial lung disease
Singing can improve the quality of life of people with lung disease and help reduce their symptoms, according…
Inhaling marijuana associated with increased odds of developing asthma
If you’re looking to reduce your chances of developing lung disease, say experts at UC San Francisco, then…